Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Blood|November 15, 2013
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutantsAllison Galanis, Hayley Ma, Trivikram Rajkhowa, et al.
Blood|November 1, 2003
Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expressionRui Zheng, Alan D Friedman, Mark Levis, et al.
Cancer Research|September 20, 2017
Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other MalignanciesJ Kyle Bruner, Hayley S Ma, Li Li, et al.
Oncology and Therapy|July 7, 2017
Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature ReviewEllen E Korol, Sisi Wang, Karissa Johnston, et al.
Blood|May 21, 2013
FLT3 inhibitor-induced neutrophilic dermatosisAmir T Fathi, Long Le, Robert P Hasserjian, et al.
Scientific Reports|March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivoNicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and AzacitidineDaniel A Pollyea, Keith W Pratz, Andrew H Wei, et al.
Blood|October 23, 2004
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survivalKyu-Tae Kim, Kristin Baird, Joon-Young Ahn, et al.
Leukemia Research|November 21, 2020
Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypesBreann Yanagisawa, Brandy Perkins, Theodoros Karantanos, et al.
Blood|May 29, 2004
Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibitionPatrick Brown, Soheil Meshinchi, Mark Levis, et al.
Pageof 16